Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure.
- 1 October 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 80 (4), 1010-1015
- https://doi.org/10.1161/01.cir.80.4.1010
Abstract
The endogenous opiate system is activated in congestive heart failure. because endogenous opioids are known to depress the baroreflex function, we conducted studies to determine whether the increased endogenous opioids play a role in causing the reduced baroreflex function that occurs in heart failure. Right-sided congestive heart failure was produced in 16 dogs by tricuspid avulsion and progressive pulmonary artery constriction. Seven sham-operated dogs were included for comparison. Baroreflex function was measured in the conscious dogs after pretreatment with either normal saline or an opiate-receptor antagonist by bolus administration of phenylephrine. The slope of the regression line relating systolic blood pressure to cardiac cycle (R-R) interval was taken as an index of baroreflex sensitivity. Plasma beta-endorphin was elevated in the dogs with heart failure (15.3 +/- 2.5 pmol/l) compared with the sham-operated dogs (4.2 +/- 0.4 pmol/l, p less than 0.001). The dogs with heart failure also exhibited a reduced baroreflex sensitivity (3.84 +/- 0.19 msec/mm Hg) after saline pretreatment when compared with the sham-operated dogs (10.86 +/- 1.20 msec/mm Hg, p less than 0.001). Administration of naloxone hydrochloride increased the baroreflex sensitivity of dogs with heart failure to 5.16 +/- 0.26 msec/mm Hg (p less than 0.01) but produced no significant effects in sham-operated dogs (11.36 +/- 1.42 msec/mm Hg). To further study the site of action for the effect of naloxone, we measured baroreflex sensitivity in the dogs with heart failure after pretreatment with naloxonazine, a selective mu-receptor antagonist, with ICI 154,129, a selective delta-receptor antagonist, or with naloxone methobromide, a quaternary analogue of naloxone that does not penetrate the blood-brain barrier.(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 27 references indexed in Scilit:
- Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephaline responsesEuropean Journal of Pharmacology, 1983
- Endogenous opioids and baroreflex control in humans.Hypertension, 1983
- Cardiovascular Effects of Endogenous Opiate SystemsAnnual Review of Pharmacology and Toxicology, 1983
- The Endorphins: A Growing Family of Pharmacologically Pertinent PeptidesAnnual Review of Pharmacology and Toxicology, 1983
- Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonistsEuropean Journal of Pharmacology, 1982
- Effects of [D-Ala2]-methionine-enkephalin on blood pressure, heart rate, and baroreceptor reflex sensitivity in conscious cats.Hypertension, 1981
- The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rateBrain Research, 1979
- Radioimmunoassays for α-endorphin and β-endorphinBiochemical and Biophysical Research Communications, 1977
- Modified technique for production of experimental right-sided congestive heart failureCardiovascular Research, 1973
- Alterations in the Baroreceptor Reflex in Conscious Dogs with Heart FailureJCI Insight, 1972